Achieve Life Sciences Ownership 2024 | Who Owns Achieve Life Sciences Now?


OverviewForecastFinancialsChartTranscripts

Institutional Ownership

0.00%

Insider Ownership

9.69%

Retail Ownership

90.31%

Institutional Holders

1.00

Achieve Life Sciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC----100-100.00%-Mar 31, 2024

Achieve Life Sciences's largest institutional shareholder is CORNERSTONE PLANNING GROUP LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC----100-100.00%-Mar 31, 2024

The largest Achieve Life Sciences shareholder by % of total assets is CORNERSTONE PLANNING GROUP LLC. The company owns 0.00 shares of Achieve Life Sciences (ACHV), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC----100-100.00%-Mar 31, 2024

As of Mar 31 2024, Achieve Life Sciences's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -0.10K stocks of ACHV, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC----100-100.00%-Mar 31, 2024

As of Mar 31 2024, Achieve Life Sciences's biggest institutional seller is CORNERSTONE PLANNING GROUP LLC. The company sold -0.10K shares of ACHV, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC----100-100.00%-Mar 31, 2024

Achieve Life Sciences's largest sold out institutional shareholder by shares sold is CORNERSTONE PLANNING GROUP LLC, sold -0.10K shares, valued at -, as of undefined.

Achieve Life Sciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.04%20,200--Dec 31, 2023
JANUS INVESTMENT FUND0.01%2,750,000--Dec 31, 2023
JANUS INVESTMENT FUND0.00%1,436,3831,436,383-Dec 31, 2023
VANGUARD INDEX FUNDS0.00%800,697252,19445.98%Dec 31, 2023
John Hancock Asset-Based Lending Fund0.00%2,637--Jan 31, 2024
JANUS INVESTMENT FUND0.00%258,074-298,875-53.66%Dec 31, 2023
VANGUARD INDEX FUNDS0.00%356,131--Dec 31, 2023
EMPOWER FUNDS, INC.0.00%970,000--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%16,807--Dec 31, 2023
EMPOWER FUNDS, INC.0.00%859,722-225,277-20.76%Dec 31, 2023
JANUS INVESTMENT FUND0.00%124,409--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%35,278--Feb 29, 2024
JANUS INVESTMENT FUND0.00%19,517-482,675-96.11%Dec 31, 2023
Legg Mason Global Asset Management Trust0.00%23,069--Jan 31, 2024
NORTHERN FUNDS0.00%14,700--Dec 29, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%2,011--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%467--Jan 31, 2024

Achieve Life Sciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 20.20K shares, compromising 0.04% of its total assets.

Achieve Life Sciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 231-
30 Jun, 2011-21.43%
31 Mar, 2014-12.50%
31 Dec, 191614.29%
30 Sep, 19147.69%
30 Jun, 191318.18%
31 Mar, 191137.50%
31 Dec, 188-52.94%
30 Sep, 181788.89%
30 Jun, 189-

As of 31 Dec 23, 1 institutions are holding Achieve Life Sciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 23100-
30 Jun, 207,172,659136.48%
31 Mar, 203,033,10429.02%
31 Dec, 192,350,82185.18%
30 Sep, 191,269,468-15.78%
30 Jun, 191,507,36035.66%
31 Mar, 191,111,093-24.35%
31 Dec, 181,468,706161.19%
30 Sep, 18562,31364.00%
30 Jun, 18342,869-

Achieve Life Sciences (ACHV) has 100.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 230.00%-
30 Jun, 20411.27%1.07%
31 Mar, 20196.08%0.85%
31 Dec, 19151.98%2.26%
30 Sep, 1982.07%0.86%
30 Jun, 1997.45%1.89%
31 Mar, 1971.83%0.80%
31 Dec, 1894.95%7.18%
30 Sep, 1836.35%7.40%
30 Jun, 1822.17%-

As of 31 Dec 23, Achieve Life Sciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Jun 20.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 231-
30 Jun, 205-50.00%
31 Mar, 2010-16.67%
31 Dec, 1912100.00%
30 Sep, 196-25.00%
30 Jun, 198-
31 Mar, 19860.00%
31 Dec, 185-66.67%
30 Sep, 181566.67%
30 Jun, 189-

1 institutional shareholders have increased their position in ACHV stock as of 31 Dec 23 compared to 5 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--
30 Jun, 201-
31 Mar, 201-75.00%
31 Dec, 194-
30 Sep, 19433.33%
30 Jun, 193200.00%
31 Mar, 191-50.00%
31 Dec, 182-
30 Sep, 18--
30 Jun, 18--

- institutional shareholders have reduced their position in ACHV stock as of 31 Dec 23 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 231-100-0.00%-1---
30 Jun, 2011-21.43%7,172,659136.48%411.27%1.07%5-50.00%1-
31 Mar, 2014-12.50%3,033,10429.02%196.08%0.85%10-16.67%1-75.00%
31 Dec, 191614.29%2,350,82185.18%151.98%2.26%12100.00%4-
30 Sep, 19147.69%1,269,468-15.78%82.07%0.86%6-25.00%433.33%
30 Jun, 191318.18%1,507,36035.66%97.45%1.89%8-3200.00%
31 Mar, 191137.50%1,111,093-24.35%71.83%0.80%860.00%1-50.00%
31 Dec, 188-52.94%1,468,706161.19%94.95%7.18%5-66.67%2-
30 Sep, 181788.89%562,31364.00%36.35%7.40%1566.67%--
30 Jun, 189-342,869-22.17%-9---

Achieve Life Sciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.58$45.85K38,501
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.91$49.06K10,000
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.58$45.85K76,724
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.91$49.06K10,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.58$45.85K38,501
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.91$49.06K10,000
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.58$45.85K76,724
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.91$49.06K10,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 23, 2024Wan Jerryofficer Principal Accounting OfficerF-InKindSell2,250$4.51$10.15K9,807
Apr 23, 2024Wan Jerryofficer Principal Accounting OfficerM-ExemptSell5,625---
Apr 23, 2024JACOBS CINDYdirector, officer President & CMOF-InKindSell3,957$4.51$17.85K30,554
Apr 23, 2024JACOBS CINDYdirector, officer President & CMOM-ExemptSell16,250---
Apr 23, 2024Stewart Richard Alistairdirector, officer Executive ChairmanF-InKindSell10,125$4.51$45.66K50,876
Apr 23, 2024Stewart Richard Alistairdirector, officer Executive ChairmanM-ExemptSell22,500---
Apr 23, 2024Bencich Johndirector, officer CEOF-InKindSell6,088$4.51$27.46K95,636
Apr 23, 2024Bencich Johndirector, officer CEOM-ExemptSell25,000---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 23, 2024Wan Jerryofficer Principal Accounting OfficerM-ExemptBuy5,625--12,057
Apr 23, 2024Wan Jerryofficer Principal Accounting OfficerF-InKindSell2,250$4.51$10.15K9,807
Apr 23, 2024Wan Jerryofficer Principal Accounting OfficerM-ExemptSell5,625---
Apr 23, 2024JACOBS CINDYdirector, officer President & CMOM-ExemptBuy16,250--34,511
Apr 23, 2024JACOBS CINDYdirector, officer President & CMOF-InKindSell3,957$4.51$17.85K30,554
Apr 23, 2024JACOBS CINDYdirector, officer President & CMOM-ExemptSell16,250---
Apr 23, 2024Stewart Richard Alistairdirector, officer Executive ChairmanM-ExemptBuy22,500--61,001
Apr 23, 2024Stewart Richard Alistairdirector, officer Executive ChairmanF-InKindSell10,125$4.51$45.66K50,876
Apr 23, 2024Stewart Richard Alistairdirector, officer Executive ChairmanM-ExemptSell22,500---
Apr 23, 2024Bencich Johndirector, officer CEOM-ExemptBuy25,000--101,724
Apr 23, 2024Bencich Johndirector, officer CEOF-InKindSell6,088$4.51$27.46K95,636
Apr 23, 2024Bencich Johndirector, officer CEOM-ExemptSell25,000---
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.58$45.85K38,501
Mar 06, 2024Stewart Richard Alistairdirector, officer Executive ChairmanP-PurchaseBuy10,000$4.91$49.06K10,000
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.58$45.85K76,724
Mar 06, 2024Bencich Johndirector, officer CEOP-PurchaseBuy10,000$4.91$49.06K10,000
Jan 29, 2024Martell Bridget Adirector-A-AwardBuy31,500$4.55$143.32K31,500
Jan 24, 2024KING THOMAS BRAXTONdirector-A-AwardBuy31,500$4.55$143.32K31,500
Jan 24, 2024Duty Stuartdirector-A-AwardBuy31,500$4.55$143.32K31,500
Jan 24, 2024Sellig Thomasdirector-A-AwardBuy31,500$4.55$143.32K31,500

The last insider sell of Achieve Life Sciences's stock was made by Wan Jerry on Apr 23 2024, selling 2,250 shares at $4.51 per share (valued at $10.15K). The last insider buy of ACHV was made by Stewart Richard Alistair on Mar 06 2024, buying 10,000 shares at $4.58 per share (worth $45.85K).

Achieve Life Sciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 202417--
Q2 20231514107.14%
Q1 2023103333.33%
Q4 20226--
Q3 20221311300.00%
Q2 2022228275.00%
Q1 20221611600.00%
Q4 2021---
Q3 20213650.00%
Q2 20214--
Q1 20211111100.00%
Q4 20205--
Q3 20202540.00%
Q2 20205--
Q1 20204--
Q3 20191333.33%
Q2 201983423.53%
Q1 2019104250.00%
Q3 2018169177.78%
Q4 2017-2-

17 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Achieve Life Sciences's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20244--
Q2 20231--
Q1 2023---
Q4 20222--
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 20211--
Q1 2021---
Q4 2020---
Q3 2020---
Q2 2020---
Q1 2020---
Q3 2019---
Q2 20193329.38%
Q1 2019---
Q3 2018---
Q4 2017---

As of Q1 2024, Insider owners conducted 4 open market buy trades and 0 open market sell trades of Achieve Life Sciences's stocks.

Achieve Life Sciences Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
CNSPCNS Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
SPROSpero Therapeutics, Inc.
TCRXTScan Therapeutics, Inc.
NXTCNextCure, Inc.
VECTVectivBio Holding AG
XFORX4 Pharmaceuticals, Inc.
ITOSiTeos Therapeutics, Inc.
INZYInozyme Pharma, Inc.
IMMXImmix Biopharma, Inc.
DAWNDay One Biopharmaceuticals, Inc.
CTMXCytomX Therapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
AVROAVROBIO, Inc.
BOLTBolt Biotherapeutics, Inc.
HEPAHepion Pharmaceuticals, Inc.
NLTXNeurogene Inc.
ASMBAssembly Biosciences, Inc.
CHRSCoherus BioSciences, Inc.

ACHV Ownership FAQ


Achieve Life Sciences is owned by institutional shareholders (0.00%), insiders (9.69%), and public (90.31%). The largest institutional shareholder of Achieve Life Sciences is CORNERSTONE PLANNING GROUP LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.04% of total shares).

Achieve Life Sciences's major institutional shareholders are CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 1 institutional shareholders of Achieve Life Sciences.

CORNERSTONE PLANNING GROUP LLC owns 0 shares of Achieve Life Sciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).